Innovative therapies offer high value but create economic pressure on healthcare systems, when used across multiple indications. IBP aims to align prices with value per indication, yet its real-world application, impact, and challenges remain insufficiently understood.
2501_Primemover_Moving from a single price mechanism to an indication-based mechanism